Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: which would be better

RE: which would be better

posted on Feb 21, 2006 12:12PM
I think a buyback program will be a 5cent or more dividend
Share
New Message
Please login to post a reply